QCOM -- which has climbed a modest 6.5% this year to land at $79.11 -- was awarded a $5 price-target hike to $90 at RBC this morning. (BMO, on the other hand, cut its price target by $2 to $88.) Meanwhile, on the options front, QUALCOMM, Inc. is staring at heavier-than-usual put open interest (compared to call open interest) among short-term options, as its Schaeffer's put/call open interest ratio (SOIR) of 0.65 ranks in the top 12% of its annual range.

MU -- which reports fiscal third-quarter earnings after the close next Monday, June 23 -- scored an upgrade to "outperform" and a price-target lift to $42 from $25 at Baird this morning. While Micron Technology, Inc. has tacked on an impressive 38.7% over the last two months to perch at $31.17, the equity still has a healthy amount of short interest stacked up against it. Currently, 10.4% of the stock's available float is sold short, and these bearish bets would take more than a week to cover, at the shares' average pace of trading. As such, MU could end up benefiting from some short-covering activity in the near term.

This morning, ORCL debuted its Oracle Health Sciences Data Management Workbench, and also received a string of bullish brokerage notes, including a $5 price-target increase to $40 at RBC. On the charts, Oracle Corporation is up more than 10% year-to-date to trade at $42.14; however, nine of its 24 covering analysts haven't given up their "hold" or "sell" suggestion. Plus, its average 12-month price target of $43.10 is just a chip-shot away from its current perch. Should ORCL continue to head north -- or see an earnings-induced spike after Thursday evening's trip to the earnings confessional -- the stock may see another round of upgrades and/or price-target hikes, which could create additional tailwinds for the shares.